Search

Bo Liang

from Rockville, MD
Age ~52
Get Report
Also known as:
Bao Leung
Related to:
Vivian V Yang, 73Katy H Yang, 66Stephen H Yang, 87Shenteng YangAnthony Tong, 31Susan Yang, 64Xijun Yang
Connected to:
A Liang, 65Abby Liang, 102Alyssa Liang, 27Andy Y Liang, 46Audrey Y Liang, 28Bernice H Liang, 58Billy C Liang, 45Caroline Liang, 30Casey Z Liang, 39Catherine Liang, 43

Bo Liang Phones & Addresses

  • Rockville, MD
  • Cockeysville, MD
  • 602 Walker Ave, Baltimore, MD 21212 (410) 372-0020
  • West Bend, WI
  • Germantown, MD
  • North Potomac, MD

Professional Records

License Records

Bo Liang

Address:
Rockville, MD
License #:
1201116219 - Expired
Category:
Cosmetologist License
Issued Date:
Feb 16, 2011
Expiration Date:
Feb 28, 2013
Type:
Cosmetologist

Resumes

Resumes

Bo Liang Photo 1

Research Fellow

View page
Location:
6001 Executive Blvd, Rockville, MD 20852
Industry:
Research
Work:
The National Institute on Drug Abuse (Nida) Oct 2013 - Oct 2015
Postdoctoral Fellow
The National Institute on Drug Abuse (Nida) Oct 2013 - Oct 2015
Research Fellow
University of Chinese Academy of Sciences Sep 2008 - Jul 2013
Graduate Student
Huazhong University of Science and Technology Sep 2007 - Jun 2008
Undergraduate Student
Education:
Institute of Optics and Electronics, Cas 2008 - 2013
Doctorates, Doctor of Philosophy, Engineering, Philosophy Huazhong University of Science and Technology 2004 - 2008
Bachelors, Medical Engineering University of Chinese Academy of Sciences
Skills:
Adaptive Optics
Optical Engineering
Biomedical Device Design
Matlab
C/C++
Originlab
Microsoft Office
Latex
Autocad
Optics
Interests:
Adaptive Optics
Noisy Observer Model
Contrast Detection In Noisy Background
Languages:
Mandarin
English
Bo Liang Photo 2

Bo Liang

View page
Bo Liang Photo 3

Bo Liang

View page
Location:
United States

Publications

Us Patents

Recombinant Chimeric Bovine/Human Parainfluenza Virus 3 Expressing Rsv G And Its Use

View page
US Patent:
20220226458, Jul 21, 2022
Filed:
Feb 1, 2022
Appl. No.:
17/590631
Inventors:
- Bethesda MD, US
Ursula J. Buchholz - Silver Spring MD, US
Bo Liang - Bethesda MD, US
Shirin Munir - Bethesda MD, US
Assignee:
The United States of America, as Represented by the Secretary, Department of - Bethesda MD
International Classification:
A61K 39/12
C07K 14/005
C12N 15/86
Abstract:
Recombinant chimeric bovine/human parainfluenza virus 3 (rB/HPIV3) vectors expressing Respiratory Syncytial Virus (RSV) G protein or a recombinant RSV G protein, as well as methods of their use and manufacture, are provided. The rB/HPIV3 vector comprises a genome comprising a heterologous gene encoding the RSV G protein or the recombinant RSV G protein. Nucleic acid molecules comprising the sequence of the genome or antigenome of the disclosed rB/HPIV3 vectors are also provided. The disclosed rB/HPIV3 vectors can be used, for example, to induce an immune response to RSV and HPIV3 in a subject.

Recombinant Chimeric Bovine/Human Parainfluenza Virus 3 Expressing Rsv G And Its Use

View page
US Patent:
20210145958, May 20, 2021
Filed:
May 29, 2018
Appl. No.:
16/616873
Inventors:
- Bethesda MD, US
Ursula J. Buchholz - Silver Spring MD, US
Bo Liang - Bethesda MD, US
Shirin Munir - Bethesda MD, US
Assignee:
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH & HUMAN SERVICES - Bethesda MD
International Classification:
A61K 39/12
C07K 14/005
C12N 15/86
Abstract:
Recombinant chimeric bovine/human parainfluenza virus 3 (rB/HPIV3) vectors expressing Respiratory Syncytial Virus (RSV) G protein or a recombinant RSV G protein, as well as methods of their use and manufacture, are provided. The rB/HPIV3 vector comprises a genome comprising a heterologous gene encoding the RSV G protein or the recombinant RSV G protein. Nucleic acid molecules comprising the sequence of the genome or antigenome of the disclosed rB/HPIV3 vectors are also provided. The disclosed rB/HPIV3 vectors can be used, for example, to induce an immune response to RSV and HPIV3 in a subject.

Recombinant Human/Bovine Parainfluenza Virus 3 (B/Hpiv3) Expressing A Chimeric Rsv/Bpiv3 F Protein And Uses Thereof

View page
US Patent:
20200277338, Sep 3, 2020
Filed:
May 18, 2020
Appl. No.:
16/877319
Inventors:
- Bethesda MD, US
Bo Liang - Boyds MD, US
Shirin Munir - Potomac MD, US
Anne Schaap Nutt - Austin TX, US
Ursula Buchholz - Silver Spring MD, US
Natalie Mackow - East Setauket NY, US
Peter Kwong - Washington DC, US
Barney Graham - Rockville MD, US
Jason McLellan - Austin TX, US
Assignee:
The United States of America, as represented by the Secretary, Department of Health and Human Servic - Bethesda MD
International Classification:
C07K 14/005
A61K 39/12
A61P 31/14
A61K 39/155
Abstract:
Recombinant paramyxoviruses including a viral genome encoding a heterologous gene are provided. In several embodiments, the recombinant paramyxovirus is a recombinant parainfluenza virus, such as a recombinant PIV3 including a viral genome encoding a heterologous respiratory syncytial virus F ectodomain linked to the transmembrane domain and the cytoplasmic tail of the F protein from the PIV3. Nucleic acid molecules including the genome of a recombinant paramyxoviruses are also provided. The recombinant viruses may advantageously be used in vaccine formulations, such as for vaccines against parainfluenza virus and respiratory syncytial virus.

Recombinant Human/Bovine Parainfluenza Virus 3 (B/Hpiv3) Expressing A Chimeric Rsv/Bpiv3 F Protein And Uses Thereof

View page
US Patent:
20180312544, Nov 1, 2018
Filed:
Jan 20, 2016
Appl. No.:
15/545218
Inventors:
- Bethesda MD, US
Bo Liang - Boyds MD, US
Shirin Munir - Bethesda MD, US
Anne Schaap Nutt - Austin TX, US
Ursula Buchholz - Silver Spring MD, US
Natalie Mackow - East Setauket NY, US
Peter Kwong - Washington DC, US
Barney Graham - Rockville MD, US
Jason McLellan - Norwich VT, US
Assignee:
The United States of America, as represented by the Secretary, Dept. of Health and Human Services - Bethesda MD
International Classification:
C07K 14/005
A61P 31/14
A61K 39/155
A61K 39/12
Abstract:
Recombinant paramyxoviruses including a viral genome encoding a heterologous gene are provided. In several embodiments, the recombinant paramyxovirus is a recombinant parainfluenza virus, such as a recombinant PIV3 including a viral genome encoding a heterologous respiratory syncytial virus F ectodomain linked to the transmembrane domain and the cytoplasmic tail of the F protein from the PIV3. Nucleic acid molecules including the genome of a recombinant paramyxoviruses are also provided. The recombinant viruses may advantageously be used in vaccine formulations, such as for vaccines against parainfluenza virus and respiratory syncytial virus.
Control profile
Bo Liang from Rockville, MD, age ~52 Get Report